ANTHONY ARIAS BRAVO: Open Payments
NPI 1508467374 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 37 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $86 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $430 |
| Amgen Inc. | 14 | $217 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Averitas Pharma Inc. | 1 | $37 |
| Organogenesis Inc. | 1 | $37 |
| Lilly USA, LLC | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
Products named: Ozempic, Wegovy, KRYSTEXXA, Rybelsus, OTEZLA, LEQVIO, QUTENZA, APLIGRAF.
Industry payments across FL — which companies pay providers there.
